BL
PALI icon

BFSG LLC’s Palisade Bio PALI Stock Holding History

BFSG LLC’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3
Closed -$16 – 664
2024
Q1 		$16 Buy
+3
New +$21 ﹤0.01% 660

Other funds holding PALI

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFSG LLC's PALI Position: Q2 2024 in Review

BFSG LLC sold out of Palisade Bio (PALI) in Q2 2024, closing a stake of 3 shares — an estimated $16 sold.

BFSG LLC first reported a position in PALI in Q1 2024 and held it in 1 quarter. The position peaked at $16 in Q1 2024. 8 funds tracked by Wall St. Rank hold PALI as of Q2 2024.

  • BFSG LLC reported no remaining Palisade Bio position as of Q2 2024 after selling out during the quarter.
  • BFSG LLC sold 3 Palisade Bio shares in Q2 2024, an estimated $16.
  • BFSG LLC first reported a position in Palisade Bio in Q1 2024 and held it in 1 quarter.
  • BFSG LLC's Palisade Bio position peaked at $16 in Q1 2024.
  • 8 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2024.

Based on BFSG LLC's 13F filing for Q2 2024, filed 29 Jul 2024.